Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...

NVAX's non-exclusive deal with PFE grants the latter access to its Matrix-M adjuvant technology. Novavax will receive $30M upfront, up to $500M in milestones, plus mid-single-digit royalties on net ...

Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary Matrix-M adjuvant technology for use in up to two disease areas. The ...

When an AMOLED screen is mentioned in a spec sheet, chances are you're talking about a smartphone. Why don't TVs use this ...